Onderneming Forma Therapeutics Holdings, Inc.
Aandelen
FMTX
US34633R1041
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 189
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd E. Shegog
DFI | Director of Finance/CFO | 59 | 01-09-19 |
President | - | 14-10-22 | |
David N. Cook
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-04-20 |
Mario Corso
IRC | Investor Relations Contact | - | 01-09-20 |
Ifeyinwa Osunkwo
PRN | Corporate Officer/Principal | - | 01-01-22 |
Ruth du Moulin
PRN | Corporate Officer/Principal | - | 16-09-20 |
Jeannette Potts
LAW | General Counsel | 62 | 01-09-19 |
Mary Wadlinger
HRO | Human Resources Officer | 64 | 11-09-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Haagen
BRD | Director/Board Member | 58 | 14-10-22 |
President | - | 14-10-22 | |
Steve Benz
BRD | Director/Board Member | - | 14-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 47 856 812 | 45 795 107 ( 95,69 %) | 4 255 ( 0,008891 %) | 95,69 % |
Bedrijfsgegevens
Forma Therapeutics Holdings, Inc.
300 North Beacon Street Suite 501
02472, Watertown
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,30% | 46,03 mld. | |
+52,73% | 44,55 mld. | |
+7,15% | 40,8 mld. | |
-8,78% | 28,25 mld. | |
+18,68% | 27,71 mld. | |
-21,92% | 18,82 mld. | |
+14,62% | 13,91 mld. | |
+31,85% | 12,43 mld. | |
+4,47% | 10,81 mld. |